Abilify

CNNMoney.comFDA rejects Wyeth anti-psychotic drugCNNMoney.com - Aug 10, 2007Generic competition would drive down revenues for competing name-brand anti-psychotics, such as Abilify from Bristol-Myers Squibb (up $0.31 to $28.49, …Abilify - Google News

Read full story